Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong

Hong Kong Medical Journal

Volumn 16, Issue SUPP3, 2010, Pages 34-37

  Hui, E P ^a   Leung, L K S ^a   Mo, F ^a   Chan, V T C ^a   Ma, A T W ^a   Poon, A ^a   Hui, E K ^a   Mak, S S ^a   Lai, M ^b   Lei, K I K ^a   Ma, B B Y ^a   Mok, T S K ^a   Yeo, W ^a   Zee, B ^b   Chan, A T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Centre for Clinical Trials   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CHEMICALLY INDUCED DISORDER; EVALUATION; FEMALE; FEVER; HONG KONG; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; NEUTROPENIA; PREDICTION AND FORECASTING; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BACTEREMIA; FEMALE; FEVER; HONG KONG; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; ROC CURVE; YOUNG ADULT;

EID: 77957902768     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988;148:2561-8.
2. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992;10:316-22.
3. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-51.
4. Paesmans M, Rapoport B, Maertens J, et al. Multicentric prospective validation of the MASCC risk-index score for identification of febrile neutropenic cancer patients at low-risk for serious medical complications. Proc Am Soc Clin Oncol 2003;22:556.
5. Uys A, Rapoport BL, Anderson R. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care in Cancer (MASCC) risk-index score. Support Care Cancer 2004;12:555-60.